Aclaris therapeutics to participate in the evercore isi 3rd annual healthconx conference

Wayne, pa., nov. 16, 2020 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that management will participate in a virtual fireside chat at the evercore isi 3rd annual healthconx conference on wednesday, december 2, 2020 at 7:30 a.m. et. management will be available december 1st and 2nd throughout the day for virtual one-on-one meetings.
ACRS Ratings Summary
ACRS Quant Ranking